About UQUIFA Group
UQUIFA Group is a Healthcare company based in Barcelona (Spain) founded in 1936, and was acquired by Vivimed Labs in December 2011. CDMO company manufacturing APIs and intermediates. UQUIFA Group has raised $42.5 million across 2 funding rounds from investors including Orbimed, Vivimed Labs and Asian Credit Fund. The company has 28 employees. UQUIFA Group has completed 1 acquisition, including Soneas. Its chief executive, as recorded, is Saurabh Gurnurkar. Its Indian entity Uquifa India Private Limited reported revenue of ₹11.17 Cr. UQUIFA Group offers products and services including API Portfolio and CDMO Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
UQUIFA Group was established in 1936 in Barcelona, Spain, as a CDMO in the pharmaceutical and chemical sectors. APIs and intermediates are produced to support customer programs for new chemical entities, spanning pre-clinical development through to commercial-scale manufacturing. Capabilities encompass hydrogenation, chlorination, and micronization processes, with operations centered in Europe.
- Headquarters Barcelona, Spain
- Employees 28
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website uquifa.com
- Social LinkedIn X
- Acquired by Vivimed Labs (Dec 2011)
- Legal Name Uquifa India Private Limited
- Date of Incorporation 12 Jul, 2017
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹11.17 Cr
FY 2023 · -15% YoY
- Indian entity net profit₹12.3 Lakh
FY 2023 · 1% margin
- Indian entity EBITDA₹35.8 Lakh
FY 2023 · 3% margin
- Total Equity Funding$42.5M (USD)
in 2 rounds
- Latest Funding Round$35.75M (USD), Debt – Conventional
Mar 2025
- InvestorsOrbimed
& 2 more
- Employee Count28
- Investments & Acquisitions
- Acquired byVivimed Labs
(Dec 2011)
Associated legal entities of UQUIFA Group
UQUIFA Group operates through Uquifa India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Uquifa India Private Limited CIN U24304TG2017FTC118240 | Active | 12 Jul 2017 | Hyderabad, Telangana | ₹11.2 Cr | 28 | 2 | View details |
Products & Services of UQUIFA Group
UQUIFA Group offers a comprehensive portfolio of products and services, including API Portfolio and CDMO Services.
Collection of active pharmaceutical ingredients for global use.
Contract development and manufacturing for pharmaceutical clients.
Funding Insights of UQUIFA Group
UQUIFA Group has successfully raised a total of $42.5M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $35.75 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.5M
- Total Rounds 2
- Last Round Debt – Conventional — $35.75M
- First Round $42.5M
(Sep 2017)
- Investors Count 2
All 2 funding rounds of UQUIFA Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $35.75M | Debt – Conventional | – | – | |
| Sep 2017 | $42.5M | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in UQUIFA Group
UQUIFA Group has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Vivimed Labs and Asian Credit Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Micro credit services are provided to underserved communities in Kazakhstan. | 1997 | asiancreditfund.com | Almaty, Kazakhstan | |
Active pharmaceutical ingredients, formulations, and specialty chemicals are manufactured. | 1988 | vivimedlabs.com | Hyderabad, India |
Investor details for UQUIFA Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Uquifa India Private Limited (UQUIFA Group)
Uquifa India Private Limited is the primary company behind UQUIFA Group. The board of Uquifa India Private Limited currently have 2 directors; the longest-serving is Saurabh Gurnurkar, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Saurabh Gurnurkar DIN 06741588 | Nominee Director | 12 Jul 2017 | 9 yrs 3 mo | Uquifa India Private Limited |
| Santosh Varalwar DIN 00054763 | Nominee Director | 12 Jul 2017 | 9 yrs 3 mo | Uquifa India Private Limited |
People of UQUIFA Group
27 people are tracked at UQUIFA Group (10 in leadership, 17 in team); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
| CEO & Managing Director | Leadership | |
Jaume Arenas | Maintenance Head | Leadership |
Pilar Valle | Chief Financial Officer | Leadership |
Alfred Pascual | Corporate Manufacturing Operations Director | Leadership |
Marta Camarero Palao | Quality Director & Qualified Person | Leadership |
Bernat Busquets Boada | Head Of Industrial Support | Leadership |
Alfred Pascual Armella | Corporate Managing Operations Director | Leadership |
Tania Tasu | VP Sales & Business Development, CDMO N.america | Leadership |
David Garcia Mateo | Head Of Logistics Sant Celoni | Leadership |
Daniel Reguant | Procurement Director | Leadership |
Luis Velasquez | Area Sales Manager | Team |
Judit Vilà | Validation & Analytical Transfer Technician | Team |
Xavi Lorente | Responsable De Validaciones Y Transferencias Analíticas En Control De Calidad | Team |
Manel Ripolles Avila | Accounts Receivable And Credit Manager | Team |
Javier Goffman Larrosa | Manager Of Corporate Projects IT / OT | Team |
Norelis Bolaños | Financial Manager | Team |
Christian Piñeiro Vizcaino | Production & Pilot Plant Manager | Team |
Rubén Jiménez Solano | Pilot Plant Manager | Team |
Jessica Sanchez | QA Manager | Team |
Anthony Morabito | Area Sales Manager | Team |
7 more people are available in the full profile.
Complete people profiles for UQUIFA Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of UQUIFA Group
Figures of Uquifa India Private Limited, the primary company behind UQUIFA Group, for FY 2023. Revenue was ₹11.17 Cr (-15% year on year). Net profit was ₹12.3 Lakh (1% margin). EBITDA was ₹35.8 Lakh (3% margin). Revenue has grown at a compounded annual rate of +7% over three years.
- ₹11.17 CrRevenue · FY 2023 · -15% YoY
- ₹12.3 LakhNet profit · 1% margin
- ₹35.8 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- 28Employees (provident fund records)
- +7%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Uquifa India Private Limited are on its company page.
Detailed financial statements for UQUIFA Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UQUIFA Group
UQUIFA Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Soneas.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CDMO with expertise in olefine metathesis reactions | soneas.com | Budapest, Hungary | 1996 | May 2018 | •••• |
Complete acquisition details for UQUIFA Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of UQUIFA Group
5 dated milestones of UQUIFA Group across 89 years, from founding to its latest funding, stage changes and deals.
- Founded UQUIFA Group is founded.
- Exit Acquired by Vivimed Labs.
- Funding First funding round of $42.5M.
- Acquisition Acquires Soneas.
- Funding Latest funding round, Debt – Conventional, of $35.8M.
Web traffic of UQUIFA Group
The website of UQUIFA Group (uquifa.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▼ 8.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Uquifa Group
Complete news archive for UQUIFA Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UQUIFA Group
UQUIFA Group was founded in 1936 and raised its 1st funding round 81 years after it was founded.
UQUIFA Group is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Saurabh Gurnurkar is the CEO of UQUIFA Group, as recorded in our data.
UQUIFA Group is a funded company, having raised a total of $42.5M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $42.5M, raised on Sep 2017.
UQUIFA Group has 28 employees.
The primary company behind UQUIFA Group, Uquifa India Private Limited, reported revenue of ₹11.17 Cr for FY 2023, down 15% year on year.
UQUIFA Group was established in 1936 in Barcelona, Spain, as a CDMO in the pharmaceutical and chemical sectors. APIs and intermediates are produced to support customer programs for new chemical entities, spanning pre-clinical development through to commercial-scale manufacturing. Capabilities encompass hydrogenation, chlorination, and micronization processes, with operations centered in Europe.
UQUIFA Group offers API Portfolio and CDMO Services.
UQUIFA Group has made 1 acquisition, including Soneas.
UQUIFA Group has 3 investors. Key investors include Orbimed, Vivimed Labs, and Asian Credit Fund.
UQUIFA Group operates through Uquifa India Private Limited.
Yes. UQUIFA Group was acquired by Vivimed Labs in December 2011.